The Asia Pacific Cardiac Catheters & Guidewires Market would witness market growth of 8.4% CAGR during the forecast period (2022-2028).
Cardiovascular disease can be identified and treated through cardiac catheterization. The use of diagnostic cardiac catheterization can be used to evaluate the existence and severity of heart illness and may aid in the diagnosis of individuals who have undergone noninvasive testing but received conflicting results.
Just prior to the surgery, a radiopaque contrast dye can be injected intravenously (IV) to aid see the coronary vessels and assessing the severity of coronary artery disease (CAD). Vascular resistance is assessed during a right heart catheterization by measuring blood oxygen saturations, heart pressures, and the degree of tricuspid/pulmonic stenosis.
This may show whether pulmonary hypertension is present and how severe it is. By monitoring the left ventricular pressure, vascular resistance, left ventricular function, and coronary artery architecture during a left heart catheterization, mitral and aortic valve functions are evaluated. Patients with blocked arteries or blood vessels may benefit from therapeutic cardiac catheterization techniques like percutaneous coronary intervention (PCI). Percutaneous vascular access is achieved by using the radial, brachial, or femoral vessels.
India, the second-most populated nation in the world, has experienced a significant demographic transition in the past 50 years, with the percentage of inhabitants over 60 nearly tripling. This pattern is probably going to last. The United Nations Department of Economic and Social Affairs predicts that by 2025, the proportion of Indians 60 and over will increase from 7.5% to 11.1%. The incidences of cardiovascular diseases are predicted to increase in the region due to a rise in the geriatric population of the region's countries.
The China market dominated the Asia Pacific Cardiac Catheters & Guidewires Market by Country in 2021; thereby, achieving a market value of $1,408 million by 2028. The Japan market is poised to grow at a CAGR of 7.7% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 9% during (2022 - 2028).
Based on Product, the market is segmented into Cardiac Catheters and Cardiac Guidewires. Based on Cardiac Catheters Type, the market is segmented into Electrophysiology Catheters, PTCA Balloons Catheters, IVUS Catheters, PTA Balloons Catheters, Guide Extension Catheters and Others. Based on End User, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Cardiac Catheters & Guidewires Market is Projected to reach USD 19 Billion by 2028, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Getinge AB, Cardinal Health, Inc., Biotronik SE & Co. KG, Medtronic PLC, Nipro Corporation, Merit Medical Systems, Inc., Teleflex, Inc. and B. Braun Melsungen AG
By Product
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
